Key result
This review examines studies comparing unprotected left main coronary stenting with CABG surgery regarding mortality, major adverse events, and repeat revascularization in high-risk ACS patients.
Why the study?
Does unprotected LMCA stenting improve outcomes compared to CABG in high surgical risk acute coronary syndrome patients?
Does unprotected LMCA stenting improve outcomes compared to CABG in high surgical risk acute coronary syndrome patients?
This review discusses the evolving role and outcomes of unprotected left main coronary stenting as an alternative to CABG for high surgical risk patients with acute coronary syndrome.
Authors
No takes yet. Share an insight, caveat, or question.
LM stenting may warrant consideration in high surgical risk ACS; leaves open comparative efficacy versus CABG pending RCTs.
Abdelmalak et al. (2013) conducted a review in Acute coronary syndrome with left main coronary artery disease. Unprotected left main coronary stenting (PCI) vs. Coronary artery bypass graft (CABG) surgery was evaluated on Mortality, major adverse events, and incidence of repeat revascularization. This review examines studies comparing unprotected left main coronary stenting with CABG surgery regarding mortality, major adverse events, and repeat revascularization in high-risk ACS patients.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: